Intermountain West Clinical Site for the Undiagnosed Disease Network (UDN) Phase 2 Supplement

项目总结/摘要 未确诊疾病网络的山间西部临床研究中心（犹他州大学）的第5年将 重点是在2022年6月30日之前完成对参与者的评估。由于暂停在 Intermountain West临床研究中心在第4年接受了其他研究中心的参与者， 来自比原先分配的地理服务范围更广的地区的申请增加了数倍 本网站第四年增加的工作量将转化为接受的参与者人数的增加， 第四年，必须在第五年进行评估。评估将遵循UDN协议，目标为一年 5完成第4年接受的所有评价。Intermountain West临床研究中心将把团队， 经验，资源和机构支持，以推进UDN的共同目标-改善诊断 以及对难以诊断的疾病和新疾病的有效、公平和可持续的管理。

PROJECT SUMMARY/ABSTRACT Year 5 of the Intermountain West Clinical Site (University of Utah) for the Undiagnosed Disease Network will be focused on completing the evaluation of participants enrolled by June 30, 2022. Because of the pause in accepting participants by other sites, the Intermountain West Clinical Site has been receiving in year 4 a several-fold increase of applications from a wider geographic catchment area than was originally assigned to the site. This increased amount of effort in year 4 will translate in increased number of participants accepted in year 4 and having to be evaluated in year 5. The evaluation will follow the UDN protocols with the goal in year 5 of completing all evaluations accepted in year 4. The Intermountain West Clinical Site will bring the team, experience, resources, and institutional support to advance the shared goal of UDN – improve the diagnosis and management of difficult-to-diagnose and new diseases—efficiently, equitably, and sustainably.